Abingdon Health plc

("Abingdon Health" or "the Company")

Salistick™ to be launched in Germany with leading retailers

Initial purchase order for 70,000 tests received

York, U.K. 17 March  2025: Abingdon Health plc (AIM: ABDX), a leading international developer, manufacturer and distributor of high quality and effective rapid tests, announces the extension of its distribution agreement with Salignostics, for the launch of an own-brand version of Salistick™, the first saliva-based pregnancy test, in a number of European territories including Germany, Poland and Austria.

After successfully launching Salistick™ in the United Kingdom, where it is now available at Superdrug, Tesco, Amazon, and under the Boots own brand range, Abingdon Health has extended its distribution agreement with Salignostics to a number of key European markets, including the German market on an exclusive basis. Abingdon Health, along with its long-standing distribution partner NeutraPharma, expects to launch an own-branded version Salistick™ with major German retailers, including DM, Rossman and Mueller, in calendar year Q2 2025.

Abingdon Health has received an initial purchase order for 70,000 tests, with further purchase orders anticipated during the calendar year 2025 on a quarterly basis.

Salistick™ is a rapid saliva-based pregnancy test that offers women a new and improved user-experience, and high accuracy for early pregnancy detection. Salistick™ is based on Salignostics' revolutionary technology which detects the pregnancy hormone β-hCG in saliva. Traditional pregnancy tests are urine-based and Salistick™ offers the ability to test anywhere, at any time.

Salignostics Ltd is an Israeli company that since 2016 has been developing cutting-edge technologies which transform saliva into a reliable body-fluid for lateral flow immunoassays like this hCG Pregnancy Rapid Test. The ingenuity of this technology lies in the ability to overcome physiological obstacles found in the chemical, biological and physical features of saliva. Salignostics' method provides a revolutionary technological platform for saliva diagnostics across a wide range of possible uses.

The Abingdon Simply Test range, including Salistick™, now includes over 16 self-tests which are sold direct-to-consumer through the Abingdon Simply Test website and through own brand and private label distribution partners in Europe. Abingdon Health will continue to expand its range of innovative self-tests that are available to consumers through partnering with innovative companies such as Salignostics to offer the very best in novel self-test technology to the market.

Chris Yates, CEO of Abingdon Health plc, commented: "We are incredibly proud and excited to be launching Salistick™, the first saliva pregnancy test, in Germany and other European territories following on from our successful commercial roll-out in the UK. This exciting innovation offers the opportunity to test for pregnancy anytime, anywhere. We are delighted to extend our partnerships with Salignostics and NeutraPharma and we look forward to continuing to work with them to bring further innovative self-test products to market."

Dr. Guy Krief Co-founder and Deputy CEO at Salignostics, commented: "We are excited to join with Abingdon Health and NeutraPharma to bring our Salistick saliva-based pregnancy test to consumers in major European territories including Germany. We believe these partnerships provide us the platform to bring this revolutionary product to pharmacy shelves throughout the region, allowing for easy and accessible pregnancy tests."

Enquiries

About Abingdon Health plc

Abingdon Health is a leading med-tech contract service provider offering its services to an international customer base.

The Group's CDMO division offers lateral flow product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health's CDMO division has the internal capabilities to take lateral flow projects, in areas such as infectious disease and clinical testing, including companion diagnostics, animal health and environmental testing, from initial concept through to routine and large-scale manufacturing; from "idea to commercial success".

Abingdon's regulatory services companies, Compliance Solutions (Life Sciences) and IVDeology, provide a broad range of regulatory services to the in vitro diagnostic and wider medical device industry, to support customers in bringing products to market across a range of territories including the USA, EU and the UK. Our consultancy services range from design, implementation and maintenance of quality management systems, preparation of technical files for regulatory approvals, part-time and interim management support, auditing both internally (e.g. Quality Management Systems) and externally (e.g. critical suppliers), management reviews and presentations, training and mentoring.

Abingdon Health's Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to empowers consumers to manage their own health and wellbeing. The Abingdon Simply Test e-commerce site offers consumers a range of information to support them in making informed decisions on the tests available. In addition, the site provides Abingdon's contract services customers with a potential route to market for self-tests. The Abingdon Simply Test range and other selected self-test products, such as the saliva pregnancy test, Salistick^TM, is also sold through international distributors and through other channels in the UK and Ireland, such as pharmacy chains.

Founded in 2008, Abingdon Health is headquartered in York, England with CDMO facilities in both York, UK and Madison, Wisconsin, USA. For more information visit: www.abingdonhealth.com